2cureX AB (2QE)
XFRA XFRA Primary XMUN Summary
2cureX AB (2QE) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has 2cureX AB ever had a stock split?
2cureX AB Profile
| Biotechnology Industry | Healthcare Sector | Mr. Dan Honeywell CEO | XFRA Exchange | SE0010468124 ISIN |
| Denmark Country | 14 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
2cureX AB (publ) is a medtech entity established in 2006, with its foundations rooted in Copenhagen, Denmark. Positioned within the European market, the company dedicates itself to the advancement and provision of innovative medical technologies aimed at enhancing cancer treatment protocols. By focusing on developing solutions that can predict a cancer patient's response to various medications, 2cureX AB stands at the forefront of personalized cancer treatment, ensuring therapies are tailored to individual patient needs, thus optimizing therapeutic outcomes.
Products and Services
- IndiTreat
An In Vitro Diagnostic (IVD) test engineered by 2cureX AB, IndiTreat's primary function is to assess the effectiveness of different drugs on cancer patients, facilitating the selection of an optimal treatment regimen. This pivotal product represents a significant advancement in personalized medicine, offering the potential to revolutionize how therapeutic strategies for cancer treatment are devised by predicting patient-specific drug responses and resistances.
- Clinical Programs
2cureX AB is engaged in the execution of various clinical programs aimed at enhancing the efficacy and applicability of IndiTreat. These programs currently encompass several types of cancer, including colorectal, ovarian, and pancreatic cancers. The objective of these clinical trials is to validate and expand the utility of IndiTreat across a broader spectrum of oncological conditions, ultimately striving to improve treatment outcomes for a wider patient demographic.
- Research and Consulting Services
Apart from its product offerings, 2cureX AB contributes to the medical and scientific community through research and consultancy. Leveraging its expertise in medtech innovations, the company offers services that support other entities in navigating complex clinical and regulatory landscapes. This facet of the company underscores its commitment to fostering advancements in healthcare technologies and patient care methodologies.
